Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

5E Advanced Materials, Inc. Director's Dealing 2025

Mar 14, 2025

34305_dirs_2025-03-14_17c5fed4-2936-4ffd-8c31-442d297a0f78.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: 5E Advanced Materials, Inc. (FEAM)
CIK: 0001888654
Period of Report: 2025-03-13

Reporting Person: BEP Special Situations IV LLC (N/A)
Reporting Person: Bluescape Energy Partners IV GP LLC (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-03-13 Common Stock A 704087 $3.5507 Acquired 7497349 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2025-03-13 Warrants $3.5507 A 2816346 Acquired Common Stock (2816346) Direct

Footnotes

F1: Bluescape Energy Partners IV GP LLC ("Bluescape GP") is the general partner of Bluescape Energy Recapitalization and Restructuring Fund IV LP, which wholly owns BEP Special Situations IV LLC ("Bluescape", together with Bluescape GP, the "Reporting Persons"). As such, Bluescape GP may be deemed to have beneficial ownership of the securities held by Bluescape. Each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.

F2: On March 13, 2025, pursuant to the January 14, 2025 Subscription Agreement, Bluescape acquired shares of common stock in a private placement transaction at a price of $3.5507 per share and warrants to acquire shares of common stock for no additional consideration.

F3: On March 13, 2025, Bluescape acquired warrants to purchase shares of common stock of the issuer in a private placement transaction. The warrants are exercisable on or after the date of issuance and will expire on March 13, 2026. The exercise price per share of common stock under the warrants is $3.5507.